Browsing Artículos by Author "Martín Mazuelos, Estrella"

Now showing items 1-2 of 2

    • Thumbnail

      Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients 

      Pemán, Javier; Zaragoza, Rafael; Quindós Andrés, Guillermo; Alkorta, Miriam; Cuétara, María S.; Camarena, Juan J.; Ramírez, Paula; Giménez, María J.; Martín Mazuelos, Estrella; Linares Sicilia, María J.; Pontón, José; Candida albicans Germ Tube Antibody Detection in Critically Ill Patients Study Group (BioMed Central, 2011-03)
      Background: Poor outcomes of invasive candidiasis (IC) are associated with the difficulty in establishing the microbiological diagnosis at an early stage. New scores and laboratory tests have been developed in order to ...
    • Thumbnail

      In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study 

      Quindós Andrés, Guillermo; Miranda Cadena, Katherine; San Millán Gutiérrez, Rosario María ORCID; Borroto Esoda, Katyna; Cantón, Emilia; Linares Sicilia, María José; Hamprecht, Axel Georg; Montesinos, Isabel; Tortorano, Anna Maria; Prigitano, Anna; Vidal García, Matxalen ORCID; Marcos Arias, Cristina; Guridi Cortaberria, Andrea ORCID; Sánchez Reus, Ferrán; Machuca Bárcena, Jesús; Rodríguez Iglesias, Manuel Antonio; Martín Mazuelos, Estrella; Castro Méndez, Carmen; López Soria, Leyre; Ruiz Gaitán, Alba; Fernández Rivero, Marcelo; Lorenzo, Damaris; Capilla, Javier; Rezusta, Antonio; Pemán, Javier; Guarro, Josep; Pereira, Joana; Célia, Pais; Romeo, Orazio; Ezpeleta Lobato, Guillermo; Jauregizar Albonigamayor, Nerea ORCID; Angulo, David; Eraso Barrio, María Elena ORCID (Frontiers Media, 2022-05)
      BackgroundIbrexafungerp (SCY-078) is the newest oral and intravenous antifungal drug with broad activity, currently undergoing clinical trials for invasive candidiasis. ObjectiveThe aim of this study was to assess the in ...